Warning messageThere is currently a suspension or adjustment to some of our activities due to COVID-19. For full details please visit our Activities in response to COVID-19 information page.
ARPANSA activities in response to COVID-19
Updated 20 October 2020
As a Federal Government Agency working under the Department of Health, ARPANSA is committed to supporting the health and safety of all Australians. During this period, as the Government works to protect the community from the effects of the novel coronavirus (COVID-19), we are working to support our staff and all stakeholders as we do our part to reduce the spread.
For up-to-date information and advice on COVID-19, please refer to the Department of Health website.
Our offices in Sydney (Miranda) and Melbourne (Yallambie) are currently closed to the public. ARPANSA maintains a reduced on-site workforce in Sydney while on-site work in Melbourne remains at a minimum in line with Victorian Stage 4 restrictions. Adjustments have been made at both sites to maintain a COVID Safe workplace.
Some activities continue to be impacted as follows:
- Regulatory activities are continuing, with the exception that remote inspections have increased and some on-site inspections have been postponed.
- Our Talk to a Scientist program continues to be available via email and our website contact form. However, phone support remains unavailable until further notice.
- Hire of radiation meters will remain unavailable until further notice.
Our Australian Clinical Dosimetry Service (ACDS) has returned to more regular on-site auditing and, using remote support where practicable, continues to support the radiation oncology community to ensure clinical obligations are met.
Other laboratories and services that were altered or temporarily unavailable during the earlier period of our response are now operational, however we anticipate some delays in service.
All other activities, including our Comprehensive Test Ban Treaty radionuclide monitoring system, medical permits, UV monitoring network and other radiation monitoring programs continue to operate as normal.
We will provide further updates to this advice as required.